OncoSec Medical (OncoSec Medical) Scaled Net Operating Assets : -0.40 (As of Jan. 2023)

View and export this data going back to 1986. Start your Free Trial

What is OncoSec Medical Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OncoSec Medical's operating assets for the quarter that ended in Jan. 2023 was $5.19 Mil. OncoSec Medical's operating liabilities for the quarter that ended in Jan. 2023 was $10.89 Mil. OncoSec Medical's Total Assets for the quarter that ended in Oct. 2022 was $14.44 Mil. Therefore, OncoSec Medical's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2023 was -0.40.

OncoSec Medical Scaled Net Operating Assets Historical Data

The historical data trend for OncoSec Medical's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical Scaled Net Operating Assets Chart

OncoSec Medical Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.27

-0.03

0.05

-0.02

OncoSec Medical Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.02	-	-	-0.07	-0.40

Competitive Comparison of OncoSec Medical's Scaled Net Operating Assets

For the Biotechnology subindustry, OncoSec Medical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoSec Medical's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoSec Medical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where OncoSec Medical's Scaled Net Operating Assets falls into.

OncoSec Medical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OncoSec Medical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jul. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jul. 2022 )
=	(Operating Assets (A: Jul. 2022 )	-	Operating Liabilities (A: Jul. 2022 ))	/	Total Assets (A: Jul. 2021 )
=	(9.578	-	9.585)	/	56.276
=	-0.00

where

	Operating Assets		(A: Jul. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	21.878	-	12.3
=	9.578

	Operating Liabilities		(A: Jul. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	15.76	-	4.127	-	2.048
=	9.585

OncoSec Medical's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jan. 2023 )
=	(Operating Assets (Q: Jan. 2023 )	-	Operating Liabilities (Q: Jan. 2023 ))	/	Total Assets (Q: Oct. 2022 )
=	(5.188	-	10.893)	/	14.439
=	-0.40

where

	Operating Assets		(Q: Jan. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	8.871	-	3.683
=	5.188

	Operating Liabilities		(Q: Jan. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	14.358	-	2.127	-	1.338
=	10.893

OncoSec Medical Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of OncoSec Medical's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoSec Medical (OncoSec Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (OTCPK:ONCSQ) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

24 North Main Street, Pennington, NJ, USA, 08534

Website

https://www.oncosec.com

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

Executives

Robert J Delaversano	officer: Principal Accounting Officer	217 W. MAIN STREET, SOMERVILLE NJ 08876
Spahr Stephany Foster	director	C/O ONCOSEC MEDICAL, 24 NORTH MAIN STREET, PENNINGTON NJ 08534
Robert H. Arch	officer: President and CEO	C/O ONCOSEC MEDICAL INCORPORATED, 24 NORTH MAIN STREET, PENNINGTON NJ 08534
George Chi	officer: Chief Financial Officer	9620 MEDICAL CENTER DRIVE, SUITE 300, ROCKVILLE MD 20850
Lin Shi	director	24 NORTH MAIN STREET, PENNINGTON NJ 08534-2218
Margaret Dalesandro	director	ONCOSEC MEDICAL INCORPORATED, 24 NORTH MAIN STREET, PENNINGTON NJ 08534
Yuhang Zhao	director	6 HORTON DR., CHESTER NJ 07930
Brian A Leuthner	officer: Chief Operating Officer	200 CONNELL DRIVE, SUITE 1600, BERKELEY HEIGHTS NJ 07922
Daniel J. O'connor	director	C/O SEELOS THERAPEUTICS, INC., 300 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
China Grand Pharmaceutical & Healthcare Holdings Ltd	10 percent owner, other: See Remarks	UNIT 3302, 33/F, THE CENTER, 99 QUEEN'S ROAD, CENTRAL K3 000000
Alpha Holdings, Inc.	director, 10 percent owner	GANGNAM-GU APGUJEONG-RO 62-GIL 17-10, SEOUL M5 06016
Kellie Malloy Foerter	officer: Chief Operating Officer	C/O ONCOSEC MEDICAL INCORPORATED, 24 N. MAIN STREET, PENNINGTON NJ 08534-2218
Herbert Kim Lyerly	director	C/O ONCOSEC MEDICAL INCORPORATED, 24 NORTH MAIN STREET, PENNINGTON NJ 08534-2218
Chao Zhou	director	UNIT 3302, 33/F, THE CENTER, 99 QUEEN'S ROAD, CENTRAL K3 000000
Grand Decade Developments Ltd	10 percent owner, other: See Remarks	UNIT 3302, 33/F, THE CENTER, 99 QUEEN'S ROAD, CENTRAL K3 000000